The agent could not access the target site directly (HTTP 403 on all fetches) and assembled an explanation entirely from web search summaries and third-party sources. The site proved completely inaccessible to direct inspection, forcing reliance on secondhand information that the agent explicitly flagged as unverified.

• ›The target domain pharmamarket.be and its sister domain pharmamarket.eu both returned HTTP 403 Forbidden on every fetch attempt (homepage, www variant, and robots.txt), making direct inspection impossible.
• ›Step [3] (web search for 'pharmamarket.be') returned only search result summaries, not full page content — the agent extracted structured facts from link titles and snippet text, not from fetched HTML.
• ›The agent had no access to current pricing, product pages, return/refund policies, or the company's own differentiation claims — all marked 'not found' because the site itself was unreachable.
• ›Conflicting data across sources (Trustpilot 4.5/5 vs. .eu site's 4.8/5 claim; ambiguity on prescription drugs) could not be resolved by visiting the authoritative source, leaving the explanation incomplete.
• ›The agent relied heavily on model memory to frame the answer structure and acknowledge gaps, since no site content was available to ground the narrative beyond brief search summaries.